在大鼠中评估酸对乙醇诱导的胃的保护作用
Fazile Nur Ekinci Akdemir1, Mustafa Can Güler2, Ersen Eraslan3
1Department of Nutrition and Dietetics, Faculty of Health Science, Ağrı İbrahim Çeçen University, Ağrı, Turkey.
Naunyn-Schmiedeberg's archives of pharmacology
|December 24, 2024
概括
酸 (SA) 通过减少氧化应激和炎症来保护免受乙醇诱导的胃. 这种天然化合物显示出作为治疗胃粘膜损伤的治疗剂的希望.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
背景情况:
- 乙醇诱导的胃是一个重大的健康问题.
- 氧化应激和炎症在病原发生中起着至关重要的作用.
- 目前的治疗方法有局限性,需要新的治疗方法.
研究的目的:
- 在大鼠模型中评估酸 (SA) 对乙醇诱导的胃的保护作用.
- 研究SA对氧化应激和炎症标志物的影响.
- 为了比较SA与奥梅普拉 (OMEP) 的疗效.
主要方法:
- 在老鼠中由乙醇诱导的胃模型.
- 在14天内口服SA (20和40毫克/公斤) 或OMEP (20毫克/公斤).
- 评估生物化学标记物 (TAS,TOS,OSI,MDA,MPO),促炎细胞因子 (TNF-α,IL-1β,IL-6),以及通过ELISA进行的细胞灭亡,组织病理学和免疫组织化学.
主要成果:
- SA显著增强了总抗氧化剂状态 (TAS) 和减少了总氧化剂状态 (TOS),氧化应激指数 (OSI),马隆迪甲 (MDA) 和髓氧化酶 (MPO) 活性.
- 抗炎症治疗有效降低了促炎性细胞因子 (TNF-α,IL-1β,IL-6) 和巴克斯表达,减轻了炎症和亡.
- 抗胰岛素的保护作用与梅的保护作用相似.
结论:
- 酸在老鼠中显示出显著的保护作用,防止乙醇诱导的胃.
- SA通过改善氧化应激和炎症反应来发挥其治疗作用.
- 酸具有作为胃的新型治疗剂的潜力,需要进一步的临床研究.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
315
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
315
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
298
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
298
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
305
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
305
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
365
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
365
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
476
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
476
Peptic Ulcer Disease I: Introduction
81
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
81


